These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20861110)

  • 21. Managing gastro-oesophageal reflux in infants.
    Drug Ther Bull; 2009 Dec; 47(12):134-7. PubMed ID: 20009040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts.
    De Jonge PJ; Siersema PD; Van Breda SG; Van Zoest KP; Bac DJ; Leeuwenburgh I; Ouwendijk RJ; Van Dekken H; Kusters JG; Kuipers EJ
    Aliment Pharmacol Ther; 2008 Jul; 28(1):127-36. PubMed ID: 18384663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facts and fantasies in extra-oesophageal symptoms in GORD.
    Labenz J
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):893-904. PubMed ID: 21126702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non response to proton pump inhibitors in gastroesophageal reflux disease].
    Lochner S; Kirch W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1956. PubMed ID: 19760560
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastro-oesophageal reflux disease: illness or illusion?
    Hungin AP
    Br J Gen Pract; 2015 Aug; 65(637):392-3. PubMed ID: 26212823
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: alginates for inadequate response to a proton pump inhibitor in gastro-oesophageal reflux disease.
    Vakil N
    Aliment Pharmacol Ther; 2016 May; 43(10):1103. PubMed ID: 27072318
    [No Abstract]   [Full Text] [Related]  

  • 30. Gastroesophageal reflux-related chronic laryngitis: con.
    Vaezi MF
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):908-9. PubMed ID: 20855684
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiac, bronchopulmonary and oropharyngeal masks of gastroesophageal reflux disease].
    Maev IV; Iurenev GL; Burkov SG
    Eksp Klin Gastroenterol; 2007; (3):27-35. PubMed ID: 17937003
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: The laryngological manifestations of reflux disease; why the scepticism?
    Mahieu HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():17-24. PubMed ID: 18081645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy.
    Leontiadis GI; Tse F
    Aliment Pharmacol Ther; 2011 May; 33(9):1068-9; author reply 1069. PubMed ID: 21453322
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mewling and puking: infantile gastroesophageal reflux in the 21st century.
    Forbes D
    J Paediatr Child Health; 2013 Apr; 49(4):259-63. PubMed ID: 23253052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Talk is cheap, often effective: symptoms in infants often respond to non-pharmacologic measures.
    Hassall E
    J Pediatr; 2008 Mar; 152(3):301-3. PubMed ID: 18280829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.